On March 2, 2017, healthcare leaders across academia and industry met to “crack the code” on heart disease and stroke advancements at the New York City American Heart Association | American Stroke Association’s Heart & Stroke Innovation Forum. This annual conference focused on big data and examined ways to improve patient care and lower heart disease and stroke costs.
More than 92 million American adults are living with some form of cardiovascular disease or the effects of stroke, and direct and indirect costs are estimated at about $316 billion, according to the AHA.
“Investment and innovation are at the foundation of medical advances that improve patient care,” says Craig Granowitz, MD, PhD, an event speaker and Chief Medical Officer at Amarin, a biopharmaceutical company. “The Heart and Stroke Innovation Forum is an outstanding collaborative meeting place that shows how payers, providers, pharma companies, and academic medical centers work together to impact patient lives.”
Attendees learned about using cutting-edge tools for preventing heart disease and delivering stroke care by speakers from IBM Watson Health, Amarin, Amazon Web Services, Harvard Medical School, Medidata Solutions, Pillo Health, Twiage, Interventional Neuro Associates, and the major New York City health systems.
Other interesting panels included conversations about preparing for value-based care and the importance of women in STEM careers.
